A Randomized Vehicle-Controlled Trial to Assess the Efficacy, Safety, and Tolerability of Ozenoxacin 1% Cream in 465 Patients 2 Years and Older With Impetigo. J of Skin 2017, 1 (3.1), s104. https://doi.org/10.25251/skin.1.supp.103.